Serial Number
90508673
Owner
McKESSON CORPORATIONAttorney
Auma N. ReggyFirst Use Date
Jan 26, 2021
Filing Date
Feb 3, 2021
MYLUNG CONSORTIUM Trademark
Serial Number: 90508673 • Registration: 6777452
Trademark Classes
Class 9 - Computers & Electronics
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Class 44 - Medical Services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Class 35 - Advertising & Business
Advertising; business management; business administration; office functions
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
February 3, 2021
Registration Date
July 5, 2022
First Use Anywhere
January 26, 2021
First Use in Commerce
January 26, 2021
Published for Opposition
April 19, 2022
Goods & Services
Downloadable electronic educational and professional publications, namely, newsletters, fact sheets, and brochures featuring information on research, testing, diagnosis, and treatment for lung cancer
Business management, business administration, and office function services in the nature of the facilitation and management of the collection, tracking, and maintenance of data relating to the testing, diagnosis, and treatment of lung cancer from medical providers, patients, medical researchers, and medical, biopharmaceutical, and biotechnology companies; business administration and office function services in the nature of the coordinating the collection, compilation, tracking, and maintenance of information and data relating to the testing, diagnosis, and treatment of lung cancer; Market intelligence services, namely, providing therapeutic insights and benchmarking information to stakeholders in the fields of medicine and healthcare; Promoting collaboration within the medical, research, scientific, and pharmaceutical, biopharmaceutical and biotechnology communities to achieve advances in lung cancer testing, diagnosis, and treatment; Promoting the exchange of information within the medical, research, scientific, and pharmaceutical, biopharmaceutical and biotechnology communities to achieve advances in lung cancer testing, diagnosis, and treatment; Providing information for the development of best practices for the testing, diagnosis, and treatment of lung cancer
Healthcare services, namely, collection of data and information on research, testing, diagnosis, and treatment of lung cancer for treatment and diagnostic purposes; Providing medical informational services for the purpose of raising awareness, and disseminating best practices for the testing, diagnosis, and treatment of lung cancer
Research services, namely, organizing collaborative research and development of protocols regarding the testing, diagnosis, and treatment of lung cancer for medical research purposes; Organizing collaboration in medical research and data collection around the testing, diagnosis, and treatment of lung cancer for medical research purposes; Organizing genomic, medical, biomedical and health care related research regarding lung cancer for medical research purposes; Providing medical research information in the field of lung cancer; Providing medical and scientific research information in the field of lung cancer